Weekly recap
IPOs, SPACs and new listings: week of Aug 3–9, 2026
Week of Aug 3–9, 2026: 5 US IPOs priced raising $1.18B; 6 SPAC IPOs; 3 SPAC deals announced; 0 deSPACs closed; 2 new IPO filings. The largest IPO was Braveheart Bio, Inc., raising $382.5M.
← Previous week Next week → All weeks
US IPOs priced5$1.18B raised
SPAC IPOs6$705M raised
SPAC deals announced3
deSPACs closed0
US IPOs, direct listings and uplistings
| Company | Type | Priced | Price | Raised | Market cap | Lead-left |
|---|---|---|---|---|---|---|
| Braveheart Bio, Inc. | IPO | Aug 6, 2026 | $18.00 | $382.5M | $1.32B | Goldman Sachs |
| Latigo Biotherapeutics, Inc. | IPO | Aug 7, 2026 | $18.00 | $345.6M | $1.14B | Goldman Sachs |
| Attovia Therapeutics, Inc. | IPO | Aug 5, 2026 | $17.00 | $289M | $731.5M | Morgan Stanley |
| BlossomHill Therapeutics, Inc. | IPO | Aug 7, 2026 | $16.00 | $150M | $490.3M | J.P. Morgan |
| Ticketplus Ltd. | IPO | Aug 7, 2026 | $8.00 | $15M | $96.5M | Bancroft |
New IPO filings
| Company | First filed | Form | Exchange |
|---|---|---|---|
| Siyata PTT | Aug 6, 2026 | F-1 | — |
| Zensitive Holding Ltd | Aug 7, 2026 | F-1 | Nasdaq Capital Market |
SPAC IPOs
| SPAC | Priced | Size | Lead underwriter |
|---|---|---|---|
| Pinnacle Acquisition Corp | Aug 7, 2026 | $200M | Santander |
| BOA Acquisition Corp. II | Aug 4, 2026 | $125M | D. Boral Capital |
| ARC Group Securities Acquisition I | Aug 5, 2026 | $105M | ARC Group |
| East West Ave Acquisition Corp. | Aug 3, 2026 | $100M | — |
| OceanLight Acquisition Corp | Aug 7, 2026 | $100M | Kingswood |
| TCGX Acquisition Corp. | Aug 6, 2026 | $75M | — |
SPAC deals announced
| SPAC | Target | Announced | Deal value |
|---|---|---|---|
| McKinley Acquisition Corp | Space-Eyes, Inc. | Aug 5, 2026 | $275M |
| Bluerock Acquisition Corp. | Bitonic Technology Labs Inc. d/b/a Yellow.ai | Aug 3, 2026 | $300M |
| Pono Capital Four, Inc. | Blackstar Orbital Technologies Corporation | Aug 6, 2026 | $380M |
SPAC mergers closed
None this week.
Reverse mergers
| Company | Public company | Event | Date |
|---|---|---|---|
| Obsidian Therapeutics, Inc. | Galera Therapeutics, Inc. | Completed | Aug 3, 2026 |
Reg A offerings qualified
| Company | Tier | Qualified |
|---|---|---|
| Newport Gold, Inc. | Tier1 | Aug 7, 2026 |
| Obsidian Prime Inc | Tier2 | Aug 6, 2026 |
Coming up
IPO calendar: deals expected to price this week and next · US IPO statistics · SPAC statistics
The free weekly recap
Every Monday: the IPOs that priced and filed, SPAC deals and closings, and what is expected to price this week, from the filings.